We feel now is a pretty good time to analyse Lumexa Imaging Holdings, Inc.'s (NASDAQ:LMRI) business as it appears the company may be on the cusp of a considerable accomplishment. Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. With the latest financial year loss of US$47m and a trailing-twelve-month loss of US$28m, the US$991m market-cap company alleviated its loss by moving closer towards its target of breakeven. The most pressing concern for investors is Lumexa Imaging Holdings' path to profitability – when will it breakeven? We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.
Consensus from 9 of the American Healthcare analysts is that Lumexa Imaging Holdings is on the verge of breakeven. They expect the company to post a final loss in 2025, before turning a profit of US$34m in 2026. So, the company is predicted to breakeven approximately a year from now or less! How fast will the company have to grow to reach the consensus forecasts that anticipate breakeven by 2026? Working backwards from analyst estimates, it turns out that they expect the company to grow 50% year-on-year, on average, which signals high confidence from analysts. Should the business grow at a slower rate, it will become profitable at a later date than expected.
Given this is a high-level overview, we won’t go into details of Lumexa Imaging Holdings' upcoming projects, though, keep in mind that typically a high forecast growth rate is not unusual for a company that is currently undergoing an investment period.
View our latest analysis for Lumexa Imaging Holdings
One thing we would like to bring into light with Lumexa Imaging Holdings is its debt-to-equity ratio of 136%. Generally, the rule of thumb is debt shouldn’t exceed 40% of your equity, and the company has considerably exceeded this. Note that a higher debt obligation increases the risk around investing in the loss-making company.
Next Steps:
This article is not intended to be a comprehensive analysis on Lumexa Imaging Holdings, so if you are interested in understanding the company at a deeper level, take a look at Lumexa Imaging Holdings' company page on Simply Wall St. We've also put together a list of pertinent aspects you should further examine:
- Valuation: What is Lumexa Imaging Holdings worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Lumexa Imaging Holdings is currently mispriced by the market.
- Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Lumexa Imaging Holdings’s board and the CEO’s background.
- Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.